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In an attempt to containMycobacterium tuberculosis,
host immune cells form a granuloma as a physical
and immunological barrier. To date, the contribution
of humoral immunity, including antibodies and spe-
cific functions of B cells, to M. tuberculosis infection
in humans remains largely unknown. Recent studies
in mice show that humoral immunity can alter M.
tuberculosis infection outcomes. M. tuberculosis in-
fection in cynomolgus macaques recapitulates essen-
tially all aspects of human tuberculosis. As a first step
toward understanding the importance of humoral im-
munity to control of M. tuberculosis infection in pri-
mates, we characterized the B-cell and plasma-cell
populations in infected animals and found that B cells
are present primarily in clusters within the granu-
loma. The B-cell clusters are in close proximity to
peripheral node addressin-positive cells and contain
cells positive for Ki-67, a proliferation marker. Gran-
uloma B cells also express CXCR5 and have elevated
HLA-DR expression. Tissues containing M. tuberculo-
sis bacilli had higher levels ofM. tuberculosis-specific
IgG, compared with uninvolved tissue from the same
monkeys. Plasma cells detected within the granuloma
produced mycobacteria-specific antibodies. Together,
these data demonstrate that B cells are present and
actively secreting antibodies specific for M. tubercu-
losis antigens at the site of infection, including lung
granulomas and thoracic lymph nodes. These anti-
bodies likely have the capacity to modulate local con-
trol of infection in tissues. (Am J Pathol 2012, 181:
508–514; http://dx.doi.org/10.1016/j.ajpath.2012.05.009)
Mycobacterium tuberculosis is an intracellular pathogen
that is the causative agent of tuberculosis (TB), an infec-
tion that is estimated to affect a third of the world’s pop-
508ulation. Ten percent of infected individuals develop clin-
ical symptoms of active TB; the remainder develop latent
infection, which is clinically asymptomatic but can reac-
tivate to cause active TB.1–3 In response to M. tuberculo-
sis infection, the host immune system forms an organized
conglomeration of cells known as a granuloma. Granulo-
mas are crucial in control of mycobacterial pathogens,
because they function as an immune and physical barrier
to prevent widespread bacterial dissemination within the
host.4 Proper control of M. tuberculosis requires immune
cells within the granuloma to kill internalized bacilli by
activating macrophages while simultaneously balancing
anti-inflammatory signals to reduce tissue damage. T
cells in particular play a critical role in activating macro-
phages via the release of interferon gamma (IFN-) and
tumor necrosis factor (TNF).5,6 The contribution of B cells
to control of human M. tuberculosis infection and pathol-
ogy remains unknown.
Upon activation by antigen, mature B cells proliferate
and differentiate into plasma cells for the sole purpose of
generating antigen-specific antibodies. Antibodies can
affect host-pathogen interactions by enhancing phago-
cytosis and antibody-dependent cell cytotoxicity, as well
as by blocking pathogen-host receptor interactions.7,8
Antibody-mediated phagocytosis can modify macrophage
behavior, depending on how the Fc portion of antibodies
interacts with the Fc receptors expressed on macro-
phages.9,10 B cells also present antigen to T cells and
enhance CD4 antigen-specific T-cell expansion.11,12 B-
cell depletion slows disease progression of what are pre-
dominantly T-cell-mediated autoimmune conditions, in-
cluding multiple sclerosis13,14 and type 1 diabetes,15 in
mice and in humans. These studies reinforce the notion
that B-cell antigen presentation is capable of mediating
further effects on T cells to drive immune activation in the
presence of antigen.
Because M. tuberculosis is primarily an intracellular
bacillus, the contribution of humoral immunity to protec-
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and early 20th centuries on the protective effects of pas-
sive immunization yielded conflicting results, which have
been attributed to variations in antisera preparation.16
M. tuberculosis infection of B-cell-deficient mice have also
yielded varied findings, ranging from increased pathol-
ogy or bacterial burden to no apparent change in disease
progression.17,18 The inconsistencies in these mouse
studies make it difficult to ascertain the role of the hu-
moral response against TB in humans. Several studies,
however, have indicated that other components of the
humoral response, including Fc receptors,19 polymeric Ig
receptors,20 and intravenous immunoglobulin,21 can af-
fect the outcome of M. tuberculosis infection in mice.
These studies suggest that B-cell responses can confer
protection against M. tuberculosis infection either directly
or by modulating cellular immune responses (eg, macro-
phages and T-cell priming and activation).
In the mouse model ofM. tuberculosis infection, B cells
are present in the lungs, often in aggregates that stain
positive for peanut agglutinin (PNA), reminiscent of ger-
minal centers in lymph nodes.17,22 Some studies have
suggested that granulomas may also function as tertiary
germinal centers, where the T-cell population is continu-
ously activated via antigen presentation by B cells. Al-
though B-cell aggregates have been identified in human
lung tissue from TB patients,23,24 how these B-cell aggre-
gates function in the context of M. tuberculosis control is
still unknown.
Our objective in the present study was to determine the
characteristics of B cells and plasma cells within granu-
lomas ofM. tuberculosis-infected cynomolgus macaques.
This nonhuman primate (NHP) model of M. tuberculosis
infection has been shown to mimic all aspects of human
TB, particularly in granuloma type and structure.
Materials and Methods
Experimental Animals
The study sample was 14 adult (4 years of age)
cynomolgus macaques (Macaca fascicularis) obtained
from Covance (Alice, TX) and from Valley Biosystems
(West Sacramento, CA) and experimentally infected with
M. tuberculosis for other studies. All animals were housed
under biosafety level 3 conditions. These studies followed
all applicable animal experimentation guidelines, and all
experimental manipulations and protocols were approved
by the University of Pittsburgh School of Medicine Institu-
tional Animal Care and Use Committee.
M. tuberculosis Infection
Cynomolgus macaques were infected with 25 to 200 CFU
of the Erdman strain of M. tuberculosis via intrabronchial
instillation, as described previously.25,26 Infection was
confirmed by conversion of negative to positive tubercu-
lin skin test and by elevated peripheral blood mononu-
clear cell responses to mycobacterial antigens relative to
baseline, as determined via lymphocyte proliferation as-
say (LPA) and enzyme-linked immunosorbent spot(ELISPOT) assay.26,27 Tissue samples for the present
study were obtained fromM. tuberculosis-infected control
monkeys used in other TB studies.
Necropsy Procedures
Monkeys were euthanized using pentobarbital and phe-
nytoin (Beuthanasia; Schering-Plough Animal Health, Ke-
nilworth, NJ) and were maximally bled before necropsy.
Gross pathological findings were described by a board-
certified veterinary pathologist (E.K.) and were classified
as described previously.25,26 Representative sections of
each tissue were placed in formalin for histological anal-
ysis or were homogenized into single-cell suspensions
for immunological studies, flow cytometric analysis, and
bacterial burden, as described previously.25–27 Bone
marrow was obtained from the sternum by flushing ex-
posed bone marrow with tissue-grade 1 PBS (Lonza,
Walkersville, MD) using a 20-gauge needle (BD, Franklin
Lakes, NJ). Red blood cells were lysed using BD Pharm
Lyse buffer (BD Biosciences, San Diego, CA), according
to the manufacturer’s instructions, before cell enumera-
tion. Tissue homogenates from numerous necropsy sam-
ples were serially diluted and plated on 7H11 agar me-
dium (BD, Sparks, MD); CFUs were enumerated on day
21. Lung samples with culturable M. tuberculosis were
classed as involved tissue and samples with no such
culturable bacteria were classed as noninvolved. Lymph-
node tissues were classified based on anatomical loca-
tion, with thoracic lymph nodes classed as lung-draining
(dLN) and other lymph nodes as peripheral (pLN).
Histological Analysis and Immunohistochemistry
Tissue sections were embedded with paraffin and
stained with H&E. These sections were then reviewed
microscopically by a veterinary pathologist (E.K.), with
specific emphasis on granuloma characteristics, as de-
scribed previously.27 Serial sections were used for immu-
nohistochemistry staining of cell markers. Briefly, slides
were processed in antigen retrieval buffer (Tris base,
0.05% Tween 20, pH 9) before staining. Antibodies used
for staining were anti-human CD20 (rabbit polyclonal;
Neomarkers, Fremont, CA), anti-human CD3 (rabbit poly-
clonal; Dako, Carpinteria, CA), anti-human Ki-67 (rabbit
polyclonal; Neomarkers), anti-mouse peripheral node ad-
dressin (PNAd) (clone MECA-79; BioLegend, San Diego,
CA), anti-rhesus CXCR5 (mouse monoclonal; NIH Non-
human Primate Reagent Resource, Boston, MA), anti-
human CD138 (clone MI5; Neomarkers), and biotinylated
PNA (Vector Laboratories, Burlingame, CA). Cell nuclei
were stained with DRAQ5 (Biostatus, Shepshed, UK).
Slides were preserved using ProLong Gold antifade re-
agent with DAPI (Invitrogen-Life Technologies, Carlsbad,
CA) before visualization under an upright confocal laser
scanning microscope (Olympus FluoView 500, model
BXL21).
For plasma cell detection, fresh tissues were fixed in
freshly prepared 4% paraformaldehyde for 6 hours at
37°C, washed with 1 PBS, and dehydrated in sucrose
solution (30% sucrose, 1 PBS) overnight at 4°C. The
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trogen. The frozen tissue was embedded in Tissue-Tek
optimal cutting temperature compound (Sakura Finetek,
Torrance, CA), and 8-m sections were cut using a cry-
ostat microtome (model HM505N; Microm International,
Walldorf, Germany) at 20°C. Sections were placed on
gelatin-coated slides and air-dried overnight at 37°C. The
slides were then stained directly, as described above.
Flow Cytometry Analysis of Surface Markers
and Quantification of B Cells within Tissue
Single-cell suspensions were derived from granuloma-
tous lung, normal lung, dLN, and pLN. Cells from these
tissue samples were stained for T cells using anti-human
CD3 (clone SP34-2; BD Biosciences) and for B cells
using anti-human CD20 (clone 2H7; eBioscience, San
Diego, CA) and T-cell costimulatory molecules CD86
(clone 2331; BD Pharmingen) and HLA-DR (clone LN3;
eBioscience). Lymphocytes were identified based on
size (forward scatter) and granularity (side scatter). B
cells and T cells were further identified based on CD20
and CD3 expression, respectively. Further character-
ization for HLA-DR and CD86 were performed within the
CD20 population. B-cell numbers within tissue were
calculated by multiplying the percentage of CD20 as
obtained from flow cytometry, with total cell numbers
obtained from tissue homogenate and normalizing to tis-
sue weight.
IgG ELISA
Supernatants obtained from tissue homogenates (granu-
lomatous lung, normal lung, dLN, and pLN) after nec-
ropsy were used to quantify total and M. tuberculosis-
specific IgG. Tissue culture-grade, 96-well, flat-bottom
Costar plates (Corning, Corning, NY) were coated with 2
g of M. tuberculosis culture filtrate protein (CFP) or
mouse anti-primate IgG (clone 8F1; NIH Nonhuman Pri-
mate Reagent Resource) dissolved in tissue-grade 1
PBS and incubated overnight at 4°C. To block the plates,
1% bovine serum albumin (BSA) in 1 PBS was used,
either at room temperature for 2 hours or overnight at 4°C.
Samples were plated in duplicate, and serial dilutions
were performed at 1:2 with 1% BSA in 1 PBS. Standard
curves were generated using purified cynomolgus ma-
caque serum IgG. Horseradish-peroxidase conjugated
mouse anti-primate IgG antibody (clone 1B3; NIH Non-
human Primate Reagent Resource) was used as the de-
tection agent (diluted at 1:5000). 3,3=,5,5=-Tetramethyl-
benzidine hydrochloride (Sigma-Aldrich, St. Louis, MO)
was used as the chromogenic substrate, according to the
manufacturer’s instructions. All incubations were per-
formed for 1 hour at 37°C unless otherwise stated. All
washes were performed with 1 PBS.
Plasma Cell ELISPOT
Ninety-six-well ELISPOT plates (Upstate; Millipore, Bil-
lerica, MA) were coated with M. tuberculosis CFP, ESAT6protein (BEI Resources, Manassas, VA), and mouse anti-
primate IgG (clone 8F1; NIH Nonhuman Primate Reagent
Resource) and then blocked as described above. Cells
from tissues obtained during necropsy (bone marrow,
granulomatous lung, normal lung, dLN, and pLN) were
resuspended to 1  106/mL in RPMI 1640 medium
(Lonza) supplemented with 1% L-glutamine and 1%
HEPES (Sigma-Aldrich) and 1.5  105 cells (150 L)
were added into each well and incubated for 16 to 20 hours
at 37°C. Horseradish peroxidase-conjugated mouse anti-
primate IgG antibody (clone 1B3; NIH Nonhuman Primate
Reagent Resource, Boston, MA) was used as the detection
agent (diluted at 1:2500) and incubated for 1 hour at 37°C.
Each well was developed using 100 L of 3-amino-9-ethyl-
carbazole (AEC) prepared according to the manufacturer’s
instructions (Vector Laboratories). All washes were per-
formed with 1 PBS.
Data Analysis
Flow cytometry data were analyzed with the FlowJo
software package version 7.6.4 (Tree Star, Ashland,
OR). Imaging data were analyzed using Prism 5
(GraphPad Software, La Jolla, CA). Fluorescent whole
granuloma images are composites of 20 to 40 images
taken at 20 magnification and assembled with Adobe
Photoshop 7 (Adobe, San Jose, CA). Statistical com-
parisons were performed using the Mann-Whitney test.
Paired samples were analyzed using the Wilcoxon
matched-pairs signed rank test. P  0.05 was consid-
ered statistically significant.
Results
Lung Granulomas of NHPs Contain Aggregates
of B Cells Reminiscent of Germinal Centers
Serial sections of NHP lung granulomas were character-
ized histologically then stained for CD3 to identify T cells,
CD20 to identify B cells, and DRAQ5 to identify cell nu-
clei. Scattered cells and aggregates of CD20 cells were
observed within the lymphocyte cuff of lung granulomas.
CD3 T cells assumed a more ubiquitous distribution
within the granuloma, compared with the clustered ap-
pearance of CD20 B cells, and were observed to be
closely associated within the B-cell clusters. CD3 T cells
were also present closer to the center of the granuloma,
which was devoid of CD20 cells (Figure 1A). We hy-
pothesized that the B-cell clusters within the granulomas
may be similar to ectopic germinal centers. To determine
whether the CD20 clusters have tertiary germinal center
characteristics,23 we stained for PNA expression (germi-
nal center B cells),28,29 anti-human Ki-67 (proliferation),
and PNAd (high endothelial venules) (Figure 1B). Within a
mature germinal center, Ki-67 cells tend to cluster at the
center of the B-cell follicle, thus delineating actively pro-
liferating cells (Figure 1C). Ki-67 nuclei were detected
within the lymphocytic cuff, indicating that active cellular
proliferation was occurring. Cells with Ki-67 nuclei were
observed within the CD20 B-cell clusters in the granu-
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distinct cluster (Figure 1D), compared with mature B-cell
germinal centers.
PNAd is important for lymphocyte chemotaxis, and
positive expression is associated with the presence of
high endothelial venules, indicative of germinal centers
(Figure 1C). PNAd cells were detected in close proxim-
ity to CD20 cells within the lymphocytic cuff of the gran-
uloma (Figure 1D).
PNA is widely used in identifying germinal centers in
mouse models, but in the present study of NHP granulo-
mas no PNA staining was noted within the CD20 clus-
ters; however, strong PNA staining was noted within the
macrophage layers of the granuloma. Very weak PNA
staining was present within the B-cell follicles of NHP
lymph nodes (data not shown). PNA also stains human
monocytes, macrophages, and plasma cells (as reported
previously18 and unpublished data). These findings sug-
Figure 1. CD20 B-cell clusters are present within macaque granulomas
and have germinal center characteristics. A: A solid granuloma (merged
image) with some caseum and a small mineralized focus was stained for
CD20 (red), CD3 (green), and nuclei with DRAQ5 (blue) to show the distri-
bution of immune cells with respect to granuloma morphology (H&E stain).
CD20 B cells and CD3 T cells (depicted as CD20 and CD3 grayscale
images, respectively) are found primarily within the lymphocytic cuff. B cells
generally form clusters, but are also present as discrete cells, whereas T cells
are usually dispersed. B: A caseous granuloma section with a mineralized
core (H&E stain) (right panel) was stained for CD20 (red), PNAd (green),
and Ki-67 (blue) to identify B cells, high endothelial venules, and prolifer-
ating cells, respectively. Two CD20 clusters were imaged in detail for
germinal center markers (boxed areas, left panel). C: A mature bronchus-
associated lymphoid tissue cluster exhibits prominent Ki-67 staining within
CD20 cells in close association with PNAd high endothelial venules
(arrow), reminiscent of B-cell follicles within lymph nodes. D: B-cell clusters
within the lymphocytic cuff of the granuloma contain some Ki-67 nuclei,
with some sporadic PNAd staining. Merged images in C and D depict CD20
(red), PNAd (green), and Ki-67 (blue). Images shown are composites of 20 to
40 images. Original magnification: 20 (B) or 40 (C and D).gest that PNA expression is very different in primates,compared with mice, and we therefore excluded PNA as
a germinal center marker. Thus, these data support that
concept that the CD20 clusters in granulomas display
some prominent characteristics of ectopic germinal cen-
ters. Further characterization of the B cells within the
granuloma was performed to assess cellular activation.
CD20 Cell Clusters within Lung Granulomas
Contain Activated B Cells
Flow cytometry was performed on single-cell suspen-
sions of lung and lymph node tissues to assess B-cell
numbers within infected tissue. Lymphocytes were iden-
tified based on size and granularity, and B cells were
further isolated based on CD20 expression (Figure 2A).
CD20 cells were found to be present at greater num-
bers within M. tuberculosis-infected lung, compared with
randomized normal lung samples, on a per-gram basis
(P  0.005). No difference in numbers of CD20 cells
was observed between dLN and pLN (Figure 2B).
Increased HLA-DR expression on B cells was used to
identify activated B cells within infected tissue, on the
premise that activated B cells have enhanced antigen
presentation capacity. The frequency of CD20 cells
from dLN or pLN expressing HLA-DR was similar (Figure
2C). However, HLA-DR expression was higher on CD20
cells from dLN, compared with pLN, within individual
animals (animals 19808 and 20908; Figure 2D). Although
HLA-DR was demonstrated on cells from involved lung
tissue, it was not possible to obtain similar data from
uninvolved lung, because insufficient B cells were pres-
ent within those tissues to allow meaningful analysis. No
appreciable difference in CD86 expression could be
seen within the CD20 cells from involved lung samples,
compared with uninvolved lung tissue (data not shown).
The chemokine receptor CXCR5 was used to identify
activated lymphocytes that respond to trafficking signals
into lymphoid tissue. CXCR5 expression was observed
on CD20 B-cell clusters within the granuloma; however,
very little colocalization of CD3 and CXCR5 was observed
within the lymphocytic cuff of the granuloma (Figure 2E).
Plasma Cells and Antibody Responses to
M. tuberculosis-Specific Antigen within
Involved Tissues
Given that B-cell clusters within the granuloma share
many germinal center characteristics, the presence of
plasma cells would further support the hypothesis that,
within the granuloma, B cells are differentiating in situ.
Plasma cells were identified within the granuloma based on
morphology (clock-faced nuclei; higher cytoplasm to nu-
clear ratio) from H&E-stained granuloma sections (Figure
3A). Staining for CD138 (a plasma cell marker in humans)
was performed on paraformaldehyde-fixed frozen gran-
uloma sections, but it failed to detect any CD138
plasma cells (data not shown). NHP lymph node samples
do contain cells stained positive with CD138 within the
B-cell follicles (data not shown).
capable of homing toward lymphoid tissue. Data are expressed as means SEM
(B and C). *P  0.05. n  7 (B and C). n.s., nonsignificant.
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ELISPOT was used to assess CFP-specific and ESAT6-
specific plasma cells within lymph node, lung, and ster-
num bone marrow samples from seven infected NHPs.
Antigen-specific plasma cells for mycobacterial antigens
(CFPs and ESAT6) within involved lung samples and for
CFP within dLN were present in greater numbers, on
average, compared with uninvolved lung samples and
pLN, respectively, although the difference did not
achieve statistical significance. However, numbers of
ESAT6-specific plasma cells were significantly greater in
dLN, compared with pLN (P  0.05) (Figure 3B). Num-
bers of plasma cells specific for CFP and ESAT6 were
similar within sternum bone marrow samples (Figure 3C).
To quantitate antibody levels within tissue samples,
lung and lymph node supernatants from 14 NHPs were
assayed by ELISA for CFP-specific IgG antibodies. Pair-
wise analysis of involved and uninvolved lung samples
from the same NHP also showed an increase in CFP-
specific IgG amounts within involved lung supernatants
(P  0.05). The same increase was observed within dLN
supernatants, compared with pLN samples (P  0.01)
(Figure 3D). Total IgG levels were similar within both lung
and lymph node groups (data not shown).
Discussion
The importance of B cells in control of human M. tuber-
culosis infection remains unclear, despite numerous stud-
ies on antibody responses in humans.16,30,31 In the pres-
ent study, we assessed the presence of B cells and
antibodies in the granulomas of M. tuberculosis-infected
macaques, using a model that accurately recapitulates
both the pathology (including granuloma types) and in-
fection outcomes seen in humans infected with M. tuber-
culosis. B cells have been demonstrated to contribute to
control of M. tuberculosis in mouse models,17 and are
reminiscent of germinal centers of lymphoid tissues
based on cell organization and chemokine response.22
However, the structure of murine granulomas is not sim-
ilar to granulomas seen in humans. Here, we demonstrate
that B cells are present as a significant population within
NHP lung granulomas and are organized into discrete
clusters with germinal center characteristics and numer-
ous plasma cells and activated B cells.
Several studies have suggested that B cells within the
granuloma are highly reminiscent of germinal centers,
based on surface marker expression.23,32 Ectopic germi-
nal center formation or lymphoid neogenesis has been
closely associated with chronic inflammation in autoim-
mune and infectious disease settings,29 and was consid-
ered a more efficient way of presenting antigen to drive
cellular activation at lesion sites. In the case of the NHP
granuloma, the B-cell clusters may be positioned within
the lymphocytic cuff evenly, like the black spots on a
white soccer ball. This may help drive antigen presenta-
tion for T-cell activation, given the similarities of granu-
loma B-cell clusters to lymph node germinal centers and
the increased HLA-DR expression present on involvedFigure 2. Activated B cells are present in mycobacteria-containing tissue. A:
Lymphocytes were gated based on size [forward scatter (FSC)] and granular-
ity [side scatter (SSC)]. B cells were further identified based on CD20
expression. The fluorescence-activated cell sorting FACS plot depicts the
cellular profile of a lymph node sample. B: Involved lung samples (Inv lung)
have at least a 10-fold increase in CD20 B cells, compared with uninvolved
lung samples (Unv lung). B-cell numbers were similar within pLN and dLN.
Each data point represents one tissue sample from one macaque. C: HLA-DR
expression by CD20 cells from dLN, although slightly elevated, was not
significantly different, compared with cells from pLN. D: In contrast, analysis
of tissues from two representative macaques (19808 and 20908) indicated ele-
vated HLA-DR expression within CD20 cells of dLN, compared with pLN of the
same macaque. CD20 from involved lung samples also stained positive for
HLA-DR (uninvolved lung lacked sufficient B-cell numbers for analysis). E:
Staining for CD3 (blue), CD20 (red), and CXCR5 (green) was done to determine
whether B-cell clusters within the granuloma behave as ectopic germinal cen-
ters. CXCR5 was used to identify lymphocytes that are actively homing toward
lymphoid tissue to identify germinal center reactions. Most of the B-cell clusters
stained positive for CXCR5 (arrows), indicating activated CD20 cells that arelung B cells. Further functional analysis may determine
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bacterial antigens and activate T-cell responses, as well
as the relative efficiency of granuloma B cells for these
processes, compared with peripheral B cells.
The increased amount of antigen-specific IgG at the
site of infection lends support to the notion that antibodies
may modulate the host-pathogen interactions in the gran-
uloma. Antigen-specific IgG-secreting plasma cells pres-
ent within lung granulomas suggest that substantial anti-
body production is occurring; however, a much greater
increase of both antigen-specific IgG and plasma cells
was noted within dLN, which indicates that M. tuberculo-
sis-specific plasma cells are being generated and pos-
sibly retained within dLN. These lymph nodes are often
infected, and usually contain M. tuberculosis-specific T
cells.25,26 It is highly likely that the plasma cells in in-
volved lung tissues are derived from activated B cells that
are recruited to the granulomas. Upon fully differentiating
into plasma cells, these terminally differentiated B cells
likely gain CD138 expression and migrate back to the
bone marrow. This would explain the absence of CD138
cells within the granuloma. Although B-cell clusters within
the granuloma share many characteristics with lymph
node germinal centers, the granuloma B-cell clusters
contain far fewer B cells, making detection of mature
CD138-expressing cells less likely.
The role of antibody remains unclear in TB. Historically,
passive immunization and serum therapy have yielded
conflicting results in human patients. Studies in humans
have been confined largely to using M. tuberculosis-spe-
cific antibodies as indicators of disease states by mea-
suring serum IgG specific to M. tuberculosis anti-
gens.30,31,33 However, there may be a role for antibodies
at the site of infection. One hypothesis is that antibody-
coated (extracellular) M. tuberculosis bacilli engage Fc
Figure 3. Granu
classical histolo
cytoplasm to nu
samples were us
plasma cells sp
macaque. Some
cells perform the
dLN, compared
be greater within
CFP and ESAT6
pairwise compa
point represents
uninvolved lung
higher levels of
presented as mereceptors (FcR) rather than just DC-SIGN and comple-ment receptors, resulting in increased macrophage acti-
vation.8,34 These changes are likely mediated by cross-
linking of Fc receptors expressed on macrophages and
neutrophils by immune complexes of IgG and M. tuber-
culosis bacilli. Data from M. tuberculosis-infected Fc re-
ceptor knockout mice also suggest that antibody-medi-
ated events are involved in the anti-TB response.19 Given
that macrophage activation is essential for control of
M. tuberculosis, antibodies may play a role in regulating
macrophage function within the granuloma. Nonetheless,
antibody-mediated phagocytosis may not necessarily be
protective, as demonstrated in dengue fever or Coxsackie
B infection.10 In rabbits infected with M. tuberculosis, in-
creased B-cell activation was observed to be associated
with failure to contain the disease.35 Antibody-dependent
enhancement of infection may also play a role in exacer-
bating the course of infection for M. tuberculosis.
Our present findings demonstrate that activated B
cells, plasma cells, and antibodies are enriched within
the granuloma, and have some characteristics of germi-
nal centers. Further studies are underway to focus on
defining the protective, pathological, or immune modula-
tory roles for these cells in TB.
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